Endocrinology, Vol 131, 1619-1628, Copyright © 1992 by Endocrine Society

ARTICLES

Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus

KC McLellan, SB Hooper, AD Bocking, PJ Delhanty, ID Phillips, DJ Hill and VK Han
Medical Research Council Group in Fetal and Neonatal Health and Development, University of Western Ontario, Lawson Research Institute, London, Canada.

Insulin-like growth factors (IGF-I and IGF-II) are potent mitogenic and differentiating peptides which are synthesized by many fetal tissues. In the circulation and tissue fluids, IGFs are bound to binding proteins (BPs) which not only function as carrier proteins, but also inhibit or modulate the biological actions of IGFs. We have previously shown that prolonged hypoxia in the ovine fetus induced by the reduction of maternal uterine blood flow for 24 h causes a reduction in the DNA synthesis rate in selected fetal tissues. To determine if this effect is due to alterations in the local synthesis of tissue IGFs and their binding proteins or to changes in systemic concentrations of IGFs and IGFBPs, we have investigated the abundance of mRNAs encoding IGFs and IGFBPs in selected tissues and changes in plasma IGFs and IGFBPs. Ovine fetuses (115-120 days gestation; n = 6) underwent 24 h of hypoxia by the reduction of maternal uterine blood flow (RUBF). Controls (n = 6) underwent the same surgical procedure without RUBF. Serial plasma samples were collected before, during, and after the experiment, and tissues were collected at the end of 24 h. Mean plasma IGF-I and IGF-II concentrations tended to be lower in hypoxic fetuses than in controls during the course of hypoxia, but these differences were not statistically significant. Tissue mRNA levels for IGF-I and IGF-II in lung, muscle, thymus, and kidney were similar in control and hypoxic fetuses after 24 h of hypoxia. The relative abundance of liver IGF-I and IGF-II mRNAs was lower in hypoxic fetuses, but only IGF-I mRNA levels were significantly different from the control values (P < 0.05). Compared to control fetuses, IGFBP-1 mRNA levels in the liver of hypoxic fetuses were increased 3- to 7-fold, and IGFBP-1 mRNA expression was induced in kidneys of some hypoxic fetuses (two of six). In addition, IGFBP-2 mRNA levels were decreased in the liver (50%) and kidney (30%) of hypoxic fetuses. The increase in liver IGFBP-1 mRNA abundance and the decrease in liver and kidney IGFBP-2 mRNA abundance were accompanied by an increase in IGFBP-1 levels and a decrease in IGFBP-2 levels in fetal plasma. No changes were observed in either plasma levels or tissue mRNA abundance for IGFBP-3. Analysis of the time course of changes in plasma revealed that the changes in IGFBP-1 and IGFBP-2 occurred within 4 h of hypoxia.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				E. J. Crespi, T. L. Steckler, P. S. MohanKumar, and V. Padmanabhan Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep J. Physiol., April 1, 2006; 572(1): 119 - 130. [Abstract] [Full Text] [PDF]

				C. S. Watson, P. Bialek, M. Anzo, J. Khosravi, S.-P. Yee, and V. K. M. Han Elevated Circulating Insulin-Like Growth Factor Binding Protein-1 Is Sufficient to Cause Fetal Growth Restriction Endocrinology, March 1, 2006; 147(3): 1175 - 1186. [Abstract] [Full Text] [PDF]

				S. Kajimura, K. Aida, and C. Duan Understanding Hypoxia-Induced Gene Expression in Early Development: In Vitro and In Vivo Analysis of Hypoxia-Inducible Factor 1-Regulated Zebra Fish Insulin-Like Growth Factor Binding Protein 1 Gene Expression Mol. Cell. Biol., February 1, 2006; 26(3): 1142 - 1155. [Abstract] [Full Text] [PDF]

				S Shaikh, F H Bloomfield, M K Bauer, H H Phua, R S Gilmour, and J E Harding Amniotic IGF-I supplementation of growth-restricted fetal sheep alters IGF-I and IGF receptor type 1 mRNA and protein levels in placental and fetal tissues J. Endocrinol., July 1, 2005; 186(1): 145 - 155. [Abstract] [Full Text] [PDF]

				S. Kajimura, K. Aida, and C. Duan From the Cover: Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation PNAS, January 25, 2005; 102(4): 1240 - 1245. [Abstract] [Full Text] [PDF]

				A M Carter, M J Kingston, K K Han, D M Mazzuca, K Nygard, and V K M Han Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs J. Endocrinol., January 1, 2005; 184(1): 179 - 189. [Abstract] [Full Text] [PDF]

				S.-T. J. HUANG, K. C. T. VO, D. J. LYELL, G. H. FAESSEN, S. TULAC, R. TIBSHIRANI, A. J. GIACCIA, and L. C. GIUDICE Developmental response to hypoxia FASEB J, September 1, 2004; 18(12): 1348 - 1365. [Abstract] [Full Text] [PDF]

				T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF]

				S. Bhatia, G. H. Faessen, G. Carland, R. L. Balise, S. E. Gargosky, M. Druzin, Y. El-Sayed, D. M. Wilson, and L. C. Giudice A Longitudinal Analysis of Maternal Serum Insulin-Like Growth Factor I (IGF-I) and Total and Nonphosphorylated IGF-Binding Protein-1 in Human Pregnancies Complicated by Intrauterine Growth Restriction J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1864 - 1870. [Abstract] [Full Text] [PDF]

				R. M. Popovici, M. Lu, S. Bhatia, G. H. Faessen, A. J. Giaccia, and L. C. Giudice Hypoxia Regulates Insulin-Like Growth Factor-Binding Protein 1 in Human Fetal Hepatocytes in Primary Culture: Suggestive Molecular Mechanisms for in Utero Fetal Growth Restriction Caused by Uteroplacental Insufficiency J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2653 - 2659. [Abstract] [Full Text] [PDF]

				L. R. Green Programming of Endocrine Mechanisms of Cardiovascular Control and Growth Reproductive Sciences, April 1, 2001; 8(2): 57 - 68. [Abstract] [PDF]

				G. A. Braems, L.-J. Yao, K. Inchley, A. Brickenden, V. K. M. Han, A. Grolla, J. R. G. Challis, and F. Possmayer Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L754 - L764. [Abstract] [Full Text] [PDF]

				R. P Holmes, J M P Holly, and P. W Soothill Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 113F - 117. [Abstract] [Full Text]

				P. Menuelle, S. Babajko, and C. Plas Insulin-Like Growth Factor (IGF) Binding Proteins Modulate the Glucocorticoid-Dependent Biological Effects of IGF-II in Cultured Fetal Rat Hepatocytes Endocrinology, May 1, 1999; 140(5): 2232 - 2240. [Abstract] [Full Text]

				S. I. Tazuke, N. M. Mazure, J. Sugawara, G. Carland, G. H. Faessen, L.-F. Suen, J. C. Irwin, D. R. Powell, A. J. Giaccia, and L. C. Giudice Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia PNAS, August 18, 1998; 95(17): 10188 - 10193. [Abstract] [Full Text] [PDF]

				J. M. Bassett and C. Hanson Catecholamines inhibit growth in fetal sheep in the absence of hypoxemia Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1536 - R1545. [Abstract] [Full Text] [PDF]

				E. Gay, D. Seurin, S. Babajko, S. Doublier, M. Cazillis, and M. Binoux Liver-Specific Expression of Human Insulin-Like Growth Factor Binding Protein-1 in Transgenic Mice: Repercussions on Reproduction, Ante- and Perinatal Mortality and Postnatal Growth Endocrinology, July 1, 1997; 138(7): 2937 - 2947. [Abstract] [Full Text] [PDF]